Published in PLoS One on April 13, 2010
Hosting infection: experimental models to assay Candida virulence. Int J Microbiol (2011) 1.14
Genetic and phenotypic intra-species variation in Candida albicans. Genome Res (2014) 1.02
Unexpected genomic variability in clinical and environmental strains of the pathogenic yeast Candida parapsilosis. Genome Biol Evol (2013) 0.91
Particular Candida albicans strains in the digestive tract of dyspeptic patients, identified by multilocus sequence typing. PLoS One (2012) 0.81
Clonal Strain Persistence of Candida albicans Isolates from Chronic Mucocutaneous Candidiasis Patients. PLoS One (2016) 0.80
Participation of Candida albicans transcription factor RLM1 in cell wall biogenesis and virulence. PLoS One (2014) 0.79
Ploidy dynamics and evolvability in fungi. Philos Trans R Soc Lond B Biol Sci (2016) 0.77
Analysis of strain relatedness using high resolution melting in a case of recurrent candiduria. BMC Microbiol (2013) 0.77
MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol (2007) 168.76
F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol (1981) 12.96
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis (2004) 6.54
Flow cytometric identification of murine neutrophils and monocytes. J Immunol Methods (1996) 4.44
Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol (2005) 4.30
Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot Cell (2004) 4.28
Immunity to fungal infections. Nat Rev Immunol (2004) 3.58
Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol (2007) 3.02
Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol (2005) 3.00
Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing. J Clin Microbiol (1995) 2.74
Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev (2007) 2.71
Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol (1986) 2.37
Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol (2006) 2.37
Collaborative consensus for optimized multilocus sequence typing of Candida albicans. J Clin Microbiol (2003) 2.17
Life and death in a macrophage: role of the glyoxylate cycle in virulence. Eukaryot Cell (2002) 1.98
Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses (2005) 1.98
Invasive candidiasis. Infect Dis Clin North Am (2006) 1.75
Microsatellite polymorphism in the promoter sequence of the elongation factor 3 gene of Candida albicans as the basis for a typing system. J Clin Microbiol (1997) 1.65
Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol (1999) 1.64
"Emergency" granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Blood (2000) 1.59
Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice. Infect Immun (2005) 1.59
Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol (1999) 1.57
Innate and adaptive immunity in Candida albicans infections and saprophytism. J Leukoc Biol (2000) 1.45
Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing. J Clin Microbiol (2006) 1.43
T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis (1995) 1.41
Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect Immun (1998) 1.38
Property differences among the four major Candida albicans strain clades. Eukaryot Cell (2009) 1.36
Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans. Microbiology (1998) 1.35
Avirulence of Candida albicans CaHK1 mutants in a murine model of hematogenously disseminated candidiasis. Infect Immun (1999) 1.30
Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis (1993) 1.29
New microsatellite multiplex PCR for Candida albicans strain typing reveals microevolutionary changes. J Clin Microbiol (2005) 1.26
Evolution in Candida albicans populations during a single passage through a mouse host. Genetics (2009) 1.24
Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia (1984) 1.24
Interactions of fungi with phagocytes. Curr Opin Microbiol (2002) 1.24
Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology (2004) 1.23
Recognition of fungal pathogens by toll-like receptors. Curr Pharm Des (2006) 1.22
Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis. Infect Immun (1999) 1.22
Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans. Antimicrob Agents Chemother (1985) 1.18
Loss of heterozygosity in commensal isolates of the asexual diploid yeast Candida albicans. Fungal Genet Biol (2008) 1.14
Microevolution of Candida albicans strains during catheter-related candidemia. J Clin Microbiol (2004) 1.13
Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts. Curr Opin Microbiol (2003) 1.10
Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans. Int Immunol (1998) 1.07
Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis. Eur J Immunol (2007) 1.03
The role of recombinant murine IL-12 and IFN-gamma in the pathogenesis of a murine systemic Candida albicans infection. J Immunol (1998) 1.00
Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.00
Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis. Oral Microbiol Immunol (2004) 0.98
Toll-like receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection. Med Mycol (2006) 0.96
The effects of population bottlenecks on clonal interference, and the adaptation effective population size. Evolution (2009) 0.94
Rethinking T cell immunity in oropharyngeal candidiasis. J Exp Med (2009) 0.94
Role of tumor necrosis factor and colony-stimulating factors in phagocyte function against Candida albicans. Diagn Microbiol Infect Dis (1991) 0.94
Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes. J Clin Microbiol (2004) 0.90
Host-pathogen interactions and the pathological consequences of acute systemic Candida albicans infections in mice. Curr Drug Targets (2006) 0.90
Uncoupling of oxidative phosphorylation enables Candida albicans to resist killing by phagocytes and persist in tissue. Cell Microbiol (2006) 0.89
Salivary cytokine profiles in the immunocompetent individual with Candida-associated denture stomatitis. Oral Microbiol Immunol (2002) 0.89
How the host fights against Candida infections. Front Biosci (Landmark Ed) (2009) 0.87
Phenotypic screening, transcriptional profiling, and comparative genomic analysis of an invasive and non-invasive strain of Candida albicans. BMC Microbiol (2008) 0.85
Mixed Candida albicans strain populations in colonized and infected mucosal tissues. FEMS Yeast Res (2008) 0.85
Neospora caninum: high susceptibility to the parasite in C57BL/10ScCr mice. Exp Parasitol (2006) 0.81
Norepinephrine as mediator in the stimulation of phagocytosis induced by moderate exercise. Eur J Appl Physiol (2004) 0.81
Comparative study of the heterophil phagocytic function in young and old ring doves (Streptopelia risoria) and its relationship with melatonin levels. J Comp Physiol B (2004) 0.81
Alterations of protein expression in macrophages in response to Candida albicans infection. Mol Cells (2005) 0.80
Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein. Microbiology (2003) 0.79
Isolates of Candida albicans that differ in virulence for mice elicit strain-specific antibody-mediated protective responses. Microbes Infect (2006) 0.78
Macrophage-colony stimulating factor is required for the production of neutrophil-promoting activity by mouse embryo fibroblasts deficient in G-CSF and GM-CSF. J Leukoc Biol (2007) 0.76
Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol (2006) 2.64
Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med (2010) 2.10
First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis (2008) 1.93
Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int J Syst Evol Microbiol (2006) 1.90
Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice. Infect Immun (2005) 1.59
Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease). PLoS Negl Trop Dis (2010) 1.48
Evidence for an intramacrophage growth phase of Mycobacterium ulcerans. Infect Immun (2006) 1.45
Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection. Infect Immun (2007) 1.40
Fine-needle aspiration, an efficient sampling technique for bacteriological diagnosis of nonulcerative Buruli ulcer. J Clin Microbiol (2009) 1.34
Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer. Lancet Infect Dis (2009) 1.27
Highly polymorphic microsatellite for identification of Candida albicans strains. J Clin Microbiol (2003) 1.27
New microsatellite multiplex PCR for Candida albicans strain typing reveals microevolutionary changes. J Clin Microbiol (2005) 1.26
α-Intercalated cells defend the urinary system from bacterial infection. J Clin Invest (2014) 1.18
Antifungal activity of the essential oil of Thymus pulegioides on Candida, Aspergillus and dermatophyte species. J Med Microbiol (2006) 1.16
Aquatic insects and Mycobacterium ulcerans: an association relevant to Buruli ulcer control? PLoS Med (2007) 1.11
Cigarette smoke increases Staphylococcus aureus biofilm formation via oxidative stress. Infect Immun (2012) 1.11
Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes. FEMS Yeast Res (2009) 1.09
Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasis. Infect Immun (2010) 1.09
IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone. J Immunol (2009) 1.08
New foci of Buruli ulcer, Angola and Democratic Republic of Congo. Emerg Infect Dis (2008) 1.06
Buruli ulcer disease: prospects for a vaccine. Med Microbiol Immunol (2009) 1.05
New polymorphic microsatellite markers able to distinguish among Candida parapsilosis sensu stricto isolates. J Clin Microbiol (2010) 1.02
Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry. J Antimicrob Chemother (2005) 1.02
Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry. J Clin Microbiol (2005) 1.01
IL-10 modulates depressive-like behavior. J Psychiatr Res (2008) 1.01
Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression. Infect Immun (2010) 1.00
Dynamics of in vitro acquisition of resistance by Candida parapsilosis to different azoles. FEMS Yeast Res (2009) 0.99
Matrix-assisted laser desorption/ionization time-of-flight intact cell mass spectrometry to detect emerging pathogenic Candida species. Diagn Microbiol Infect Dis (2011) 0.98
Gellan gum injectable hydrogels for cartilage tissue engineering applications: in vitro studies and preliminary in vivo evaluation. Tissue Eng Part A (2010) 0.97
SYBR green as a fluorescent probe to evaluate the biofilm physiological state of Staphylococcus epidermidis, using flow cytometry. Can J Microbiol (2011) 0.94
Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection. PLoS One (2012) 0.92
Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination. PLoS One (2012) 0.92
Aggressive mature natural killer cell neoplasms: report on a series of 12 European patients with emphasis on flow cytometry based immunophenotype and DNA content of neoplastic natural killer cells. Leuk Lymphoma (2014) 0.92
TLR2 deficiency by compromising p19 (IL-23) expression limits Th 17 cell responses to Mycobacterium tuberculosis. Int Immunol (2010) 0.90
Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model. PLoS Negl Trop Dis (2013) 0.90
The C allele of rs5743836 polymorphism in the human TLR9 promoter links IL-6 and TLR9 up-regulation and confers increased B-cell proliferation. PLoS One (2011) 0.90
Study of molecular epidemiology of candidiasis in portugal by PCR fingerprinting of Candida clinical isolates. J Clin Microbiol (2004) 0.89
Optimization of a flow cytometry protocol for detection and viability assessment of Giardia lamblia. Travel Med Infect Dis (2008) 0.89
Mycobacterium tuberculosis Strains Are Differentially Recognized by TLRs with an Impact on the Immune Response. PLoS One (2013) 0.88
Increased number of glutamine repeats in the C-terminal of Candida albicans Rlm1p enhances the resistance to stress agents. Antonie Van Leeuwenhoek (2009) 0.88
Expression of plasma coagulase among pathogenic Candida species. J Clin Microbiol (2003) 0.87
Microfluidic assembly of multistage porous silicon-lipid vesicles for controlled drug release. Lab Chip (2014) 0.87
Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection. PLoS Negl Trop Dis (2012) 0.87
A flow cytometric protocol for detection of Cryptosporidium spp. Cytometry A (2008) 0.86
Rapid identification of Sporothrix species by T3B fingerprinting. J Clin Microbiol (2012) 0.86
β-Hemolysin/cytolysin of Group B Streptococcus enhances host inflammation but is dispensable for establishment of urinary tract infection. PLoS One (2013) 0.85
Differential arabinan capping of lipoarabinomannan modulates innate immune responses and impacts T helper cell differentiation. J Biol Chem (2012) 0.84
Farnesol, a fungal quorum-sensing molecule triggers Candida albicans morphological changes by downregulating the expression of different secreted aspartyl proteinase genes. Open Microbiol J (2011) 0.84
Deferred consent in a minimal-risk study involving critically ill subarachnoid hemorrhage patients. Can Respir J (2014) 0.83
Specific detection of Pneumocystis jirovecii in clinical samples by flow cytometry. Methods Mol Biol (2013) 0.83
Differential post-transcriptional regulation of IL-10 by TLR2 and TLR4-activated macrophages. Eur J Immunol (2013) 0.83
Isolates from hospital environments are the most virulent of the Candida parapsilosis complex. BMC Microbiol (2011) 0.83
Evidence for diversifying selection in a set of Mycobacterium tuberculosis genes in response to antibiotic- and nonantibiotic-related pressure. Mol Biol Evol (2013) 0.83
Vaginolysin drives epithelial ultrastructural responses to Gardnerella vaginalis. Infect Immun (2013) 0.82
Barriers to recruit female commercial sex workers for HIV vaccine trials: the Rio de Janeiro experience. J Acquir Immune Defic Syndr (2009) 0.81
Microsatellite multilocus genotyping clarifies the relationship of Candida parapsilosis strains involved in a neonatal intensive care unit outbreak. Diagn Microbiol Infect Dis (2011) 0.81
Genetic relatedness and antifungal susceptibility profile of Candida albicans isolates from fungaemia patients. Med Mycol (2010) 0.81
A new model of laryngitis: neuropeptide, cyclooxygenase, and cytokine profile. Laryngoscope (2008) 0.80
Vascular endothelial growth factor and fibroblast growth factor-2 incorporation in starch-based bone tissue-engineered constructs promote the in vivo expression of neovascularization mediators. Tissue Eng Part A (2013) 0.80
Microsatellite typing identifies the major clades of the human pathogen Candida albicans. Infect Genet Evol (2010) 0.80
Plasmacytoid and conventional dendritic cells are early producers of IL-12 in Neospora caninum-infected mice. Immunol Cell Biol (2009) 0.80
In vivo performance of chitosan/soy-based membranes as wound-dressing devices for acute skin wounds. Tissue Eng Part A (2013) 0.79
TLR9 activation dampens the early inflammatory response to Paracoccidioides brasiliensis, impacting host survival. PLoS Negl Trop Dis (2013) 0.79
Dextrin nanoparticles: studies on the interaction with murine macrophages and blood clearance. Colloids Surf B Biointerfaces (2009) 0.79
Immune response in the adipose tissue of lean mice infected with the protozoan parasite Neospora caninum. Immunology (2015) 0.79
P. brasiliensis virulence is affected by SconC, the negative regulator of inorganic sulfur assimilation. PLoS One (2013) 0.79
The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment. Inflamm Res (2010) 0.78
Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic. PLoS One (2010) 0.78
Confinement effects on drugs in thermally hydrocarbonized porous silicon. Langmuir (2014) 0.77
Bacterial cellulose: long-term biocompatibility studies. J Biomater Sci Polym Ed (2012) 0.77
Poly(methyl vinyl ether-alt-maleic acid)-functionalized porous silicon nanoparticles for enhanced stability and cellular internalization. Macromol Rapid Commun (2014) 0.77
Surface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug delivery. Nanoscale (2015) 0.76
Chitosan improves the biological performance of soy-based biomaterials. Tissue Eng Part A (2010) 0.76
Host defense mechanisms in invasive candidiasis originating in the GI tract. Expert Rev Anti Infect Ther (2008) 0.76
Chemokine receptor repertoire reflects mature T-cell lymphoproliferative disorder clinical presentation. Blood Cells Mol Dis (2008) 0.76
Microbiological and physicochemical characterization of olive mill wastewaters from a continuous olive mill in Northeastern Portugal. Bioresour Technol (2008) 0.76
Isoenzyme patterns: a valuable molecular tool for the differentiation of Zygosaccharomyces species and detection of misidentified isolates. Syst Appl Microbiol (2004) 0.76
Protective effect of intranasal immunization with Neospora caninum membrane antigens against murine neosporosis established through the gastrointestinal tract. Immunology (2014) 0.75
Unraveling the uptake mechanisms of mannan nanogel in bone-marrow-derived macrophages. Macromol Biosci (2012) 0.75
Colonization of central venous catheters in intensive care patients: a 1-year survey in a Portuguese University Hospital. Am J Infect Control (2010) 0.75